You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Novel, Nanostructured, Metal-organic Frameworks-Based Product Loss Prevention Technology in the Oil and Natural Gas Sector
SBC: FRAMERGY INC Topic: 17NCER2CTo reach the end user, oil and gas production at the wellhead must be transmitted through the country and distributed to a wide range of customers. This logistical system requires natural gas gathering lines, processing facilities, product storage tanks and lots of other equipment. What results is air pollution caused by industry losses during these operations and the use of continuous or intermit ...
SBIR Phase I 2018 Environmental Protection Agency -
A universal eye drop adherence monitor to measure and improve adherence to ocular medications
SBC: Universal Adherence LLC Topic: NProject Summary Abstract Universal Adherence is an emerging medical device company dedicated to improving adherence to ocular medications through innovative technical solutionsOur proposed Devers Drop DeviceDwill accurately track when a patient removes an eye drop bottle capcommunicate usage data wirelessly to a database that researchers can accessand send alerts to patients when a medication is d ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Development of a Yellow Fever Vaccine for a Vulnerable Population
SBC: NAJIT TECHNOLOGIES INC Topic: NIAIDABSTRACT Yellow fever virus (YFV) represents a mosquito-borne emerging/re-emerging human pathogen that causes 20- 50% mortality and is endemic in andgt;40 countries. The current live attenuated YFV vaccine was developed in 1936 and following the establishment of a virus seed lot system, it has not been modified or otherwise improved in over 50 years. According to the CDC, this vaccine causes 47 se ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
A High-Throughput, Multi-Omic Assay of Tumor Biomarkers from Single-Cells
SBC: ISOPLEXIS CORPORATION Topic: 172SUMMARY Although solid tumors oftentimes arise from the uninhibited growth of a single aberrant cellthe population of cells within a tumor are genetically and molecularly heterogenousThis makes it very difficult to evaluate a therapy s efficacy when using bulk population measurementsFurthermorerecent research has implicated microRNAsmiRNAsas drivers of progression and malignancy in many tumor type ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Advancing Human Health by Lowering Barriers to Electrophysiology in Genetic Model Organisms
SBC: NEMAMETRIX, INC Topic: 300Project Summary The nematode worm Caenorhabditis elegans has proven valuable as a model for many high impact medical conditionsThe strength of Celegans derives from the extensive homologies between human and nematode genesand the many powerful tools available to manipulate genes in Celegansincluding expressing human genesResearchers utilizing medical models based on Celegans have converged on two ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Factor XI inhibitor for thrombosis
SBC: ARONORA INC Topic: NHLBIProject Summary Although potent antithrombotic agents are availableall of these drugs inadvertently target vital hemostatic molecular mechanismsresulting in dose limiting hemorrhagic toxicity that restrict their useDue to a lack of safe thromboprophylaxisthrombotic blood vessel occlusions continue to be extremely prevalentand result in a wide range of severe disease conditions that remain the lead ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis
SBC: GLYCOMIRA, LLC Topic: NIAIDPROJECT SUMMARY Chronic rhinosinusitis (CRS) is one of the most prevalent inflammatory diseases in the U.S., affecting up to 16% of the population and substantially diminishing the quality of life and productivity of patients. In four years, the annual U.S. health care expenditure to treat patients with CRS dramatically increased from $9B to $64B (5% of the health care budget), with a correspondin ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Enhanced Recovery of Pharmaceutical Solvent driven by EPA Initiative
SBC: COMPACT MEMBRANE SYSTEMS, INC. Topic: NIEHSSummary Enhanced Recovery of Pharmaceutical Solvent driven by EPA InitiativeThe United States Environmental Protection AgencyEPAis establishing new safeguards for hazardous secondary materials with objectives to promote the economicenvironmentaland public health benefits of recycling wasteswith an emphasis on several industrial sectorsincluding the pharmaceutical industryOn averagepharmaceutical m ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Mobility Rehab: A Biofeedback System for Mobility Rehabilitation for Older Adults
SBC: APDM, INC. Topic: NIAProject Summary Mobility limitations including gait and balance impairments are common in older adultsespecially those with neurological de citsGait and balance impairments are a major cause of falls and reduced quality of lifeAlthough laboratory studies show that biofeedback during exercise training can improve motor performancephysical therapists do not have access to an overground gait biofeedb ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
HLS-Affordable, quantitative microchip-electrophoresis for sickle cell disease screening
SBC: HEMEX HEALTH INC Topic: NHLBIPROJECT SUMMARY Sickle Cell DiseaseSCDaffectsAmericans and more thanmillion people globallyprimarily in economically disadvantaged populationsIt is estimated that nearlyof children born with SCD in these areas die before the age of fivealthoughcould be saved through simplecost effective treatments if diagnosed early according to World Health OrganizationEarly diagnosis of SCD remains a challenge i ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health